Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 91 | 1 | 7 | 0 | €1,052.2 | €1,087.1 | 3.318% |
| Boston Scientific | 77 | 0 | 11 | 0 | €44.36 | €83.22 | 87.625% |
| UnitedHealth Group Inc. | 76 | 2 | 11 | 0 | €348.40 | €368.94 | 5.896% |
| Intuitive Surgical Inc | 72 | 2 | 15 | 0 | €347.60 | €512.03 | 47.303% |
| Abbott Laboratories | 69 | 0 | 8 | 0 | €95.08 | €114.37 | 20.289% |
| Gilead Sciences Inc | 67 | 0 | 4 | 0 | €117.62 | €128.68 | 9.400% |
| Johnson & Johnson | 57 | 0 | 10 | 0 | €225.00 | €228.39 | 1.507% |
| HCA Holdings Inc. | 55 | 2 | 7 | 1 | €356.60 | €435.61 | 22.158% |
| Dexcom Inc. | 53 | 2 | 10 | 0 | €77.60 | €75.81 | -2.306% |
| AbbVie Inc. | 46 | 0 | 5 | 0 | €216.60 | €228.85 | 5.657% |
| Regeneron Pharmaceuticals Inc. | 45 | 0 | 4 | 0 | €691.10 | €730.15 | 5.650% |
| Biogen Inc. | 42 | 1 | 9 | 0 | €176.68 | €203.01 | 14.905% |
| Vertex Pharmaceuticals Inc. | 42 | 1 | 4 | 0 | €458.85 | €475.00 | 3.520% |
| Medtronic plc | 41 | 1 | 1 | 0 | €78.52 | €97.41 | 24.051% |
| Amgen Inc. | 42 | 4 | 7 | 2 | €358.95 | €340.76 | -5.068% |
| Agilent Technologies Inc. | 34 | 0 | 1 | 0 | €129.50 | €137.44 | 6.131% |
| Cigna Corp. | 32 | 0 | 1 | 0 | €237.20 | €286.34 | 20.718% |
| Edwards Lifesciences Corp. | 31 | 0 | 7 | 0 | €81.16 | €85.42 | 5.249% |
| Thermo Fisher Scientific Inc. | 30 | 0 | 1 | 0 | €524.00 | €538.69 | 2.803% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 3 | 0 | €60.26 | €73.11 | 21.329% |
| Stryker Corp. | 27 | 0 | 5 | 0 | €301.60 | €350.80 | 16.312% |
| Merck & Co. Inc. | 26 | 0 | 6 | 0 | €113.00 | €122.85 | 8.717% |
| Humana Inc. | 32 | 7 | 8 | 0 | €324.00 | €186.51 | -42.434% |
| Incyte Corp. | 25 | 1 | 7 | 0 | €104.90 | €114.79 | 9.432% |
| Elanco Animal Health Inc. | 24 | 0 | 2 | 0 | €19.72 | €25.33 | 28.461% |

